Pharmaceutical strategies in the emerging era of antibody-based biotherapeutics for the treatment of cancers overexpressing MET receptor tyrosine kinase.
Drug Discov Today
; 26(1): 106-121, 2021 01.
Article
em En
| MEDLINE
| ID: mdl-33171292
ABSTRACT
Pharmaceutical innovation in the development of novel antibody-based biotherapeutics with increased therapeutic indexes makes MET-targeted cancer therapy a clinical reality.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Biofarmácia
/
Proteínas Proto-Oncogênicas c-met
/
Antineoplásicos Imunológicos
/
Neoplasias
Limite:
Humans
Idioma:
En
Revista:
Drug Discov Today
Ano de publicação:
2021
Tipo de documento:
Article